Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.
Table of Contents
|2 Why Combinations and Collaborations Are Necessary||3-10|
|3 Scientific Challenges in Developing Investigational Combination Therapies||11-36|
|4 Overcoming Cultural Challenges to Collaborations||37-42|
|5 Legal Issues in Collaborations||43-52|
|6 Financial Challenges||53-54|
|7 Regulatory Issues||55-62|
|8 Codevelopment of Therapies for HIV as a Model||63-68|
|9 Examples of Collaborations Relevant to Cancer||69-72|
|10 Wrapping Up||73-76|
|Appendix A: Examples of Collaborations||77-90|
|Appendix B: Workshop Agenda||91-96|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary...